Patent application number | Description | Published |
20130181295 | ANALOG SIGNAL COMPATIBLE CMOS SWITCH AS AN INTEGRATED PERIPHERAL TO A STANDARD MICROCONTROLLER - At least one analog signal compatible complementary metal oxide semiconductor (CMOS) switch circuit is incorporated with digital logic circuits in an integrated circuit. The integrated circuit may further comprise a digital processor and memory, e.g., microcontroller, microprocessor, digital signal processor (DSP), programmable logic array (PLA), application specific integrated circuit (ASIC), etc., for controlling operation of the at least one analog signal compatible CMOS switch for switching analog signals, e.g., audio, video, serial communications, etc. The at least one analog signal compatible CMOS switch may have first and second states, e.g., single throw “on” or “off”, or double throw common to a or b, controlled by a single digital control signal of either a logic “0” or a logic “1”. | 07-18-2013 |
20150061727 | Analog Signal Compatible CMOS Switch as an Integrated Peripheral to a Standard Microcontroller - At least one analog signal compatible complementary metal oxide semiconductor (CMOS) switch circuit is incorporated with digital logic circuits in an integrated circuit. The integrated circuit may further comprise a digital processor and memory, e.g., microcontroller, microprocessor, digital signal processor (DSP), programmable logic array (PLA), application specific integrated circuit (ASIC), etc., for controlling operation of the at least one analog signal compatible CMOS switch for switching analog signals, e.g., audio, video, serial communications, etc. The at least one analog signal compatible CMOS switch may have first and second states, e.g., single throw “on” or “off”, or double throw common to a or b, controlled by a single digital control signal of either a logic “0” or a logic “1”. | 03-05-2015 |
Patent application number | Description | Published |
20100220414 | HEAD GIMBAL ASSEMBLY WITHOUT BUS TRACES FOR PLATING - Head gimbal assemblies for data storage systems are provided. Some embodiments include a dielectric layer having a first and a second side. A first conductive layer is on the first dielectric layer. The first conductive layer includes a pad and a trace. A second conductive layer is on the second dielectric side. A via extends from the first dielectric layer side to the second dielectric layer side. The via electrically connects the first conductive layer to the second conductive layer. | 09-02-2010 |
20100315744 | SLIDER-GIMBAL SCRATCH MITIGATION - A head gimbal assembly for use with a load beam includes a gimbal, a slider for carrying a transducing head, and first and second tabs. The gimbal is configured to be supported by the load beam, and includes a gimbal tongue. At least a portion of the slider is secured to the gimbal tongue. The first tab extends from the gimbal tongue proximate a first corner of the slider. The second tab is spaced from the first tab and extends from the gimbal tongue proximate a second corner of the slider. | 12-16-2010 |
20100315745 | PROTECTIVE LAYER ON GIMBAL FOR SCRATCH MITIGATION - A head gimbal assembly includes a gimbal, a slider, and a polymer layer. The gimbal comprises a metal layer, and the metal layer of the gimbal defines a gimbal mounting portion for attachment to a metallic load beam and a gimbal tongue extending from the gimbal mounting portion. The slider comprises a ceramic material for carrying a transducing head, and at least a portion of the slider is secured to the gimbal tongue. The polymer layer is positioned adjacent to the gimbal and configured for limiting ceramic-to-metal and metal-to-metal contact. | 12-16-2010 |
Patent application number | Description | Published |
20090155884 | AVIAN LEUKOSIS VIRUSES AND POLYPEPTIDE DISPLAY - The invention provides methods and materials involved in displaying polypeptide sequences using viruses such as avian leukosis viruses. Specifically, the invention provides nucleic acid molecules, collections of nucleic acid molecules, polypeptides, collections of polypeptides, viruses, and collections of viruses as well as methods for making nucleic acid molecules, collections of nucleic acid molecules, polypeptides, collections of polypeptides, viruses, and collections of viruses. The invention also provides methods for obtaining displayed polypeptide sequences that interact with biological molecules and/or cells as well as methods for identifying biological molecules that interact with displayed polypeptides. | 06-18-2009 |
20100098632 | HYDROXYAPATITE PARTICLES - This document provides methods and materials related to hydroxyapatite particles. For example, hydroxyapatite particles, methods for making hydroxyapatite particles, and methods for using hydroxyapatite particles are provided herein. | 04-22-2010 |
20100111873 | TREATING CANCER WITH VIRAL NUCLEIC ACID - This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided. | 05-06-2010 |
Patent application number | Description | Published |
20080227740 | Compositions and Methods for Elimination of Unwanted Cells - Disclosed are compositions comprising a recombinant nucleic acid vector including a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface, and a host cell containing the recombinant vector and expressing the syncytium inducing polypeptide on its cell surface, the vectors and resultant host cells expressing the syncytium inducing polypeptide being useful for selective elimination of unwanted cells. | 09-18-2008 |
20090004149 | METHOD FOR LIMITING THE GROWTH OF CANCER CELLS USING AN ATTENUATED MEASLES VIRUS - A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 10 | 01-01-2009 |
20100099182 | SYSTEM FOR MONITORING THE LOCATION OF TRANSGENES - A novel strategy for monitoring the location of a transgene in a mammal is disclosed. A sodium iodide symporter is genetically fused to either the N-terminus or C-terminus of the product of a transgene through a linker peptide which bears the recognition sequence of a host cell protease. Expression of the transgene confers the activity of the sodium iodide symporter (NIS) to a host cell which expresses the transgene. Subsequent administration of labeled iodine results in transport of the labeled iodine into the cell bearing the NIS, which can then be localized and measured using standard imaging techniques. The system is particularly useful for monitoring the location of therapeutic transgenes and tissue-specific distribution of the therapeutic gene product. | 04-22-2010 |
20100119548 | METHOD FOR LIMITING THE GROWTH OF CANCER CELLS USING AN ATTENUATED MEASLES VIRUS - A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 10 | 05-13-2010 |
20130251681 | VESICULAR STOMATITIS VIRUSES - This document provides methods and materials related to vesicular stomatitis viruses. For example, vesicular stomatitis viruses, nucleic acid molecules encoding VSV polypeptides, methods for making vesicular stomatitis viruses, and methods for using vesicular stomatitis viruses to treat cancer are provided. | 09-26-2013 |
20130345414 | TREATING CANCER WITH VIRAL NUCLEIC ACID - This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided. | 12-26-2013 |
20140024100 | MEASLES VIRUSES WITH REDUCED SUSCEPTIBILITY TO NEUTRALIZATION - This document provides methods and materials for making and using measles viruses having a reduced susceptibility to antibody neutralization (e.g., antibody neutralization by monoclonal anti-measles virus antibodies and/or serum from measles virus vaccinees). For example, H polypeptides having a reduced ability of being recognized by anti-measles virus antibodies that were generated against a wild-type measles virus or a pre-existing measles virus vaccine such as MV-Edm as compared to a wild-type measles virus H polypeptide or the H polypeptide of MV-Edm are provided. | 01-23-2014 |
20140271456 | RADIOTRACER IMAGING USING SODIUM IODIDE SYMPORTER POLYPEPTIDES - This document provides methods and materials involved in radiotracer imaging using NIS polypeptides. For example, methods and materials for performing imaging techniques that increase the detection sensitivity and resolution of radiotracers localized by NIS reporter gene expression and/or decrease background signals that can be attributed to endogenously expressed NIS polypeptides are provided. | 09-18-2014 |
20140271564 | VESICULAR STOMATITIS VIRUSES CONTAINING A MARABA VIRUS GLYCOPROTEIN POLYPEPTIDE - This document provides methods and materials related to vesicular stomatitis viruses containing a G polypeptide of a maraba virus. For example, vesicular stomatitis viruses containing a G polypeptide of a maraba virus (e.g., pseudotyped viruses), nucleic acid molecules encoding vesicular stomatitis viruses containing a G polypeptide of a maraba virus, methods for making vesicular stomatitis viruses containing a G polypeptide of a maraba virus, and methods for using vesicular stomatitis viruses containing a G polypeptide of a maraba virus to treat cancer or infectious diseases are provided. | 09-18-2014 |
20150079037 | REPLICATION-COMPETENT VESICULAR STOMATITIS VIRUSES - This document provides methods and materials related to vesicular stomatitis viruses. For example, replication-competent vesicular stomatitis viruses, nucleic acid molecules encoding replication-competent vesicular stomatitis viruses, methods for making replication-competent vesicular stomatitis viruses, and methods for using replication-competent vesicular stomatitis viruses to treat cancer or infectious diseases are provided. | 03-19-2015 |